Paper41244792
Current status, challenges, and integration pathways of biomarker classification systems in graft-versus-host disease: a preliminary exploration.
Yu X and 7 others. Front Med (Lausanne), 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Current status, challenges, and integration pathways of biomarker classification systems in graft-versus-host disease: a preliminary exploration. Papers, record 41244792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41244792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Current status, challenges, and integration pathways of biomarker classification systems in graft-versus-host disease: a preliminary exploration.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References126
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27217465 | Biomarker Panel for Chronic Graft-Versus-Host Disease. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/27217465 | PubMed |
| 2 | 35030629 | Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease. | Blood Adv | 2022 | https://conductscience.org/library/papers/35030629 | PubMed |
| 3 | 35634722 | Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction. | Am J Transplant | 2022 | https://conductscience.org/library/papers/35634722 | PubMed |
| 4 | 39489917 | Ex vivo-generated human CD1c+ regulatory B cells by a chemically defined system suppress immune responses and alleviate graft-versus-host disease. | Mol Ther | 2024 | https://conductscience.org/library/papers/39489917 | PubMed |
| 5 | 38117900 | Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/38117900 | PubMed |
| 6 | 28665299 | Cytokine mediators of chronic graft-versus-host disease. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28665299 | PubMed |
| 7 | 31406955 | Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology. | JCO Precis Oncol | 2019 | https://conductscience.org/library/papers/31406955 | PubMed |
| 8 | 38113462 | Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions. | Blood Adv | 2024 | https://conductscience.org/library/papers/38113462 | PubMed |
| 9 | 27365424 | TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment. | Blood | 2016 | https://conductscience.org/library/papers/27365424 | PubMed |
| 10 | 32534102 | Suppression of Hematopoietic Primitive Cells in Patients with Secondary Failure of Platelet Recovery after Acute Graft-versus-Host Disease. | Biol Blood Marrow Transplant | 2020 | https://conductscience.org/library/papers/32534102 | PubMed |
| 11 | 38543084 | Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy? | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38543084 | PubMed |
| 12 | 31434801 | A panel of 4 biomarkers for the early diagnosis and therapeutic efficacy of aGVHD. | JCI Insight | 2019 | https://conductscience.org/library/papers/31434801 | PubMed |
| 13 | 23200544 | Have we made progress in the treatment of GVHD? | Best Pract Res Clin Haematol | 2012 | https://conductscience.org/library/papers/23200544 | PubMed |
| 14 | 37480848 | Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity. | Immunity | 2023 | https://conductscience.org/library/papers/37480848 | PubMed |
| 15 | 29348127 | Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. | Blood | 2018 | https://conductscience.org/library/papers/29348127 | PubMed |
| 16 | 39017661 | Oral and Gut Microbiome Alterations in Oral Chronic GVHD Disease: Results from Close Assessment and Testing for Chronic GVHD (CATCH Study). | Clin Cancer Res | 2024 | https://conductscience.org/library/papers/39017661 | PubMed |
| 17 | 34816294 | Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy. | Ann Hematol | 2022 | https://conductscience.org/library/papers/34816294 | PubMed |
| 18 | 34658668 | Childhood Allergy Disease, Early Diagnosis, and the Potential of Salivary Protein Biomarkers. | Mediators Inflamm | 2021 | https://conductscience.org/library/papers/34658668 | PubMed |
| 19 | 33139661 | Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33139661 | PubMed |
| 20 | 30106382 | Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. | J Clin Invest | 2018 | https://conductscience.org/library/papers/30106382 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41244792
GET https://conductscience.org/api/papers/v1/41244792/references?page=2